Compliance, Capital, and the Deal ft. James Carey

In this episode of The Compliance Advantage, Ross Ronan sits down with James Carey, a seasoned private equity and growth equity professional with deep experience in healthcare investing. James shares what investors are actually looking for when they evaluate healthcare companies, why transparency in the diligence process builds stronger deals, and how a well-run compliance program directly affects a company's attractiveness to outside capital. From revenue cycle management and coding distribution to payer mix and reimbursement trends, this conversation gives healthcare founders and CEOs a clear picture of what it means to be investment-ready. Topics covered in this episode: What experienced healthcare investors look for when evaluating a business for the first time Why transparency in the diligence process builds trust and leads to better outcomes for founders How coding distribution and payer mix affect investor confidence and deal structure Why smaller practices are often less optimized from a compliance and billing standpoint, and what that means for growth The reimbursement risk conversation happening inside investment committees right now How the No Surprises Act and state-by-state regulatory differences affect multi-location healthcare businesses Why cash pay and functional health businesses are growing, and where compliance fits into that trend What founders should do before they ever sit down with an investor Connect with James:   / jamesjcarey   James Carey is a private equity and growth equity professional with deep experience in healthcare investing. His background spans origination, investment analysis, due diligence, and portfolio optimization, with a focus on partnering with founders and management teams on strategic growth initiatives.